Bartonella species infection in cats : ABCD guidelines on prevention and management by Pennisi, M.G. et al.
 http://jfm.sagepub.com/
Journal of Feline Medicine and Surgery
 http://jfm.sagepub.com/content/15/7/563
The online version of this article can be found at:
 
DOI: 10.1177/1098612X13489214
 2013 15: 563Journal of Feline Medicine and Surgery
Alan D Radford, Etienne Thiry, Uwe Truyen and Marian C Horzinek
Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Tim Gruffydd-Jones, Margaret J Hosie, Hans Lutz, Karin Möstl, 
Maria Grazia Pennisi, Fulvio Marsilio, Katrin Hartmann, Albert Lloret, Diane Addie, Sándor Belák, Corine
 Species Infection in Cats: ABCD guidelines on prevention and managementBartonella
 
 
technique does not amount to an endorsement of its value or quality, or the claims made by its manufacturer.
those of the authors and the inclusion in this publication of material relating to a particular product, method or 
of animals and interpretation of published materials lies with the veterinary practitioner. The opinions expressed are
from actions or decisions based on information contained in this publication; ultimate responsibility for the treatment 
arisingcountry. The authors, editors, owners and publishers do not accept any responsibility for any loss or damage 
advertising material, it is the responsibility of the reader to check that the product is authorised for use in their own
bear this in mind and be aware of the prescribing laws pertaining to their own country. Likewise, in relation to 
Furthermore, drugs may be mentioned that are licensed for human use, and not for veterinary use. Readers need to
formulations that are not available or licensed in the individual reader's own country.





 International Society of Feline Medicine
 
 American Association of Feline Practitioners
and
 http://www.sagepublications.com





 http://jfm.sagepub.com/cgi/alertsEmail Alerts: 
 





 What is This?
 
- Jun 27, 2013Version of Record >> 
 at Universite de Liege on September 3, 2013jfm.sagepub.comDownloaded from 
JFMS CLINICAL PRACTICE 563
Journal of Feline Medicine and Surgery (2013) 15, 563–569
European Advisory Board 
on Cat Diseases
www.abcd-vets.org
Corresponding author: Maria Grazia Pennisi
Email: pennipet@unime.it
DOI: 10.1177/1098612X13489214
© Published by SAGE on behalf of ISFM and AAFP 2013
C L I N I C A L R E V I EW
BARTONELLA SPECIES INFECTION IN CATS
ABCD guidelines on prevention 
and management
Maria Grazia Pennisi, Fulvio Marsilio, Katrin Hartmann, Albert Lloret, 
Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink,
Tadeusz Frymus, Tim Gruffydd-Jones, Margaret J Hosie, Hans Lutz, Karin
Möstl, Alan D Radford, Etienne Thiry, Uwe Truyen and Marian C Horzinek
Bacterial properties
Bartonella (previously named Rochalimaea) species are small, vector-
transmitted Gram-negative intracellular bacteria that are well adapted
to one or more mammalian reservoir hosts.
To date, over 22 Bartonella species have been described, but their role
as pathogens of humans and domestic animals is the subject of on -
going investigations (Table 1).1 The most common species in both cats
and humans is B henselae, the agent of cat scratch disease as well as of
other potentially fatal disorders in immunocompromised people. 
B henselae is naturally transmitted among cats by the flea Ctenocephalides
felis felis, or by





by the flea, and the
bacterium survives
in the flea’s gut.
Contaminated flea
faeces deposited on
the skin of the cat end
up under the cat’s claws
due to self-scratching. A cat scratch is the common mode of transmission
of the organism to other animals, including humans.2
B henselae has been experimentally transmitted among cats by trans-
ferring fleas fed on naturally infected cats to specific pathogen-free
(SPF) cats, and by intradermal inoculation of excrement collected from
fleas fed on B henselae-infected cats.2 This has demonstrated that both
the vector and the cat – through scratches – may transmit the organism.
Infection is amplified in the flea hindgut, and B henselae can persist in
the environment in flea faeces for at least 9 days.3 Blood transfusion
also represents a risk: cats have been experimentally infected with 
B henselae and B clarridgeiae by intravenous or intramuscular inocula-
tion with infected cat blood.4
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD) is a body
of experts in immunology, vaccinology and clinical feline medicine
that issues guidelines on prevention and management of feline
infectious diseases in Europe, for the benefit of the health and
welfare of cats. The guidelines are based on current scientific
knowledge of the diseases and available vaccines concerned.
The latest version of the Bartonella species infection 
in cats guidelines is available at www.abcd-vets.org
Overview: Over 22 Bartonella species have been
described in mammals, and Bartonella henselae
is most common worldwide. Cats are the main
reservoir for this bacterium. B henselae is the
causative agent of cat scratch disease in man, 
a self-limiting regional lymphadenopathy, but
also of other potentially fatal disorders in
immunocompromised people. 
Infection: B henselae is naturally transmitted
among cats by the flea Ctenocephalides felis
felis, or by flea faeces. A cat scratch is the
common mode of transmission of the organism
to other animals, including humans. Blood
transfusion also represents a risk.
Disease signs: Most cats naturally infected 
by B henselae do not show clinical signs but
cardiac (endocarditis, myocarditis) or ocular
(uveitis) signs may be found in sporadic cases. 
B vinsonii subspecies berkhoffii infection has
reportedly caused lameness in a cat affected by
recurrent osteomyelitis and polyarthritis.
Diagnosis: Isolation of the bacterium is the gold
standard, but because of the high prevalence 
of infection in healthy cats in endemic areas, a
positive culture (or polymerase chain reaction) 
is not confirmatory. Other compatible diagnoses
must be ruled out and response to therapy gives
a definitive diagnosis. Serology (IFAT or ELISA) 
is more useful for exclusion of the infection
because of the low positive predictive value
(39–46%) compared with the good negative
predictive value (87–97%). Laboratory testing 
is required for blood donors.
Disease management: Treatment is
recommended in the rare cases where Bartonella
actually causes disease. 
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B henselae transmission did not occur when
infected cats lived together with uninfected
cats in a flea-free environment. Transmission
consequently does not occur through bites,
scratches (in the absence of fleas), grooming,
or sharing of litter boxes and food dishes.
Furthermore, transmission could not be
demonstrated between bacteraemic female
cats and uninfected males during mating, or
to the kittens of infected females either during
gestation or in the neonatal period, again in
flea-free environments.5
Ticks may also act as vectors for transmis-
sion among cats, human beings, dogs and
other mammalian hosts: trans-stadial trans-
mission of B henselae was demonstrated in
Ixodes ricinus.6
Epidemiological evidence and experimental
studies have demonstrated the important role
of fleas in the transmission of B henselae and 
B clarridgeiae among cats. Three other species,
B koehlerae, B bovis and B quintana, have been
isolated from cat blood, but the modes of
transmission and the reservoir potential of
these species in felids have not been estab-
lished. In addition, B vinsonii subspecies berk-
hoffii DNA was detected in the blood of a cat.7
Epidemiology
Bartonella species have a worldwide distribu-
tion, with highest prevalences in areas where
conditions are most favourable for arthropod
vectors, mainly fleas. In Europe, many studies
have been carried out and the antibody preva-
lence in cats has ranged from 8–53% (Table 2).
Pathogenesis
Chronic bacteraemia mainly occurs in young
cats, under the age of 2 years.20 Young experi-
mentally infected cats maintained relapsing 
B henselae or B clarridgeiae bacteraemia for as
long as 454 days.21 Immune system avoidance
via intracellular location, frequent genetic
rearrangements and alteration of outer 
membrane proteins are considered important
factors for the maintenance of persistent 
bacteraemia. The location within erythrocytes
and vascular endothelial cells is believed to
protect Bartonella also from antimicrobial
agents. 
As the host-adapted reservoir of B henselae,
cats display minimal pathogenic effects after
experimental infection. Gross necropsy find-
ings were unremarkable in experimentally
infected cats but some histopathological
changes emerged: follicular hyperplasia of
lymph nodes and spleen, lymphocyte and
plasma cell infiltrates in liver, heart, kidney
and eye, and pyogranulomatous inflamma-
tion in liver, spleen, kidney, heart and lymph
nodes.5,21
Immunity
The antibody response to B henselae has been
investigated for the identification of vaccine
candidates. The kinetics in response to B hense-
lae antigens in chronically infected experimen-
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B henselae can persist in the environment 
in flea faeces for at least 9 days.
Bartonella species Primary reservoir Vector Accidental host
B bacilliformis Human Lutzomyia
verrucarum
None
B quintana* Human Pediculus humanus Cat, dog, monkey
B elizabethae Rattus
norvegicus
Xenopsylla cheopis Human, dog
B grahamii Several species
of wild mice
Rodent fleas Human
B henselae* Cat Ctenocephalides
felis felis (C felis)
Other vectors?
Human, dog
B clarridgeiae* Cat C felis Human, dog
B koehlerae* Cat C felis Human
B vinsonii subspecies
berkhoffii*









B asiatica Rabbit Fleas? Human
*Zoonotic species
Species and subspecies of Bartonella that are
confirmed or potential human pathogens1
Table 1
Country Number of cats Prevalence (%) Reference 
Netherlands 163 (stray) 52 Bergmans et al (1997)8
Austria 96 33 Allerberger et al (1995)9





Haimerl et al (1999)11







Chomel et al (1995)13
Heller et al (1997)14
Gurfield et al (2001)15





Fabbi et al (2004)17
Brunetti et al (2013)18
Scotland 78 15.3 Bennett et al (2011)19
Antibody prevalence of Bartonella infection 
in the feline population in European countries
Table 2
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tal cats is highly variable in degree and dura-
tion.2,21,22 Reinfection by a different strain of 
B henselae is possible, as supported by the isola-
tion of unrelated bacterial clones from the same
cat at different times.23 Antibodies are, there-
fore, considered not protective, and Bartonella
species antibody positive cats may be infect-
ed.17 A cell-mediated response was not evident
in investigated experimentally infected cats.21
Clinical signs
Cats naturally infected with Bartonella species
usually do not show clinical signs. Both exper-
imental and natural infection studies have
tried to establish an association between clini-
cal signs and infection, but a link has not been
unequivocally proven. 
Experimental infection
Exposure to infected fleas does not result in
clinical signs [EBM grade II].2,24 In some cases
of experimental inoculation, a self-limiting
febrile disease, transient mild anaemia,
localised or generalised lymphadenopathy,
mild neurological signs and reproductive fail-
ure have been reported [EBM grade III].21
Natural infection
The role of Bartonella as a cause of clinical signs
is even more unclear after natural infection
despite a plethora of studies. Studies based on
antibody detection are of limited value
because antibody only proves exposure, and
not necessarily an active infection. Moreover,
there is cross-reactivity between different
Bartonella species and strains that may or may
not cause clinical signs. Because of the high
percentage of infected healthy cats in endemic
areas an association between clinical signs and
B henselae infection is not easy to demonstrate.
It has been suggested that Bartonella infec-
tion could play a role in chronic gingivo -
stomatitis, but the prevalence of antibodies  
or organisms was not higher in diseased 
cats than in control populations [EBM grade
II].10,25–30
Cats positive for both feline immunodefi-
ciency virus (FIV) and Bartonella antibodies
had in one study an increased risk of lym-
phadenopathy [EBM grade III].25
An association between Bartonella antibod-
ies and urinary tract disease or haematuria
was found in two studies [EBM grade III].10,31
Pearce et al did not find any difference in
antibody prevalence between healthy cats 
and cats with seizures or other neurological 
conditions.32 A non-controlled retrospective
study reported Bartonella DNA and antibodies
in cerebrospinal fluid from cats with CNS 
disease [EBM grade III].33
No difference in Bartonella antibody preva-
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lence was found between healthy cats and
those affected by uveitis, but in some cases evi-
dence of Bartonella species exposure was report-
ed in cats with uveitis responsive to drugs
considered effective against Bartonella [EBM
grade IV].34–36
No difference in Bartonella antibody preva-
lence was found in cats affected by anaemia,
but in cats positive for Bartonella antibodies a
significant association with hyperglobuli-
naemia was seen [EBM grade I].37,38 Lappin et
al demonstrated no association between fever
and positivity to Bartonella antibodies or
DNA.39
A study based on serology and culture did
not find an association between Bartonella
infection and chronic rhinosinusitis.40 Also no
link was reported between Bartonella infection
and pancreatitis, based on the finding that
cats with normal feline pancreatic lipase
immunoreactivity values and cats with elevat-
ed values did not show any difference in
Bartonella antibody prevalence.41
A few case reports concern B henselae-associ-
ated endocarditis or myocarditis. Fatal aortic
and mitral valve B henselae-associated endo-
carditis was reported in two cats in the
USA.42,43 Moreover, B henselae anterior mitral
valve leaflet vegetative endocarditis was suc-
cessfully treated in a cat presenting with a
grade III/IV systolic heart murmur and signs
of aortic embolisation (lethargy and weakness
in the hind limbs, weak femoral pulses, pelvic
pain, increased serum creatine kinase activi-
ty).44 This case report confirms that Bartonella
species may be a cause of blood culture-
negative endocarditis, as suspected.45
Bartonella-associated myocarditis was suspect-
ed in a cat presenting with supraventricular














Figure 1 Gross and histological findings in two cats from a North Carolina shelter that died
after a litter of flea-infested kittens was introduced to the shelter. (a) Coalescing granulomas
distributed throughout the myocardium of an approximately 9-week-old female kitten. 
(b) Pyogranulomatous myocarditis in an 8-month-old castrated male cat, which had been 
co-housed with the flea-infested kittens. Macrophages, with a rare multinucleated giant cell
(arrow), are particularly numerous towards the upper left of the image; haematoxylin and eosin
stain. Inset: Cluster of short bacilli in an inflammatory focus are immunoreactive (brown) 
for B henselae-specific monoclonal antibody; immunohistochemistry with diaminobenzidine
chromogen and haematoxylin counterstain. Reproduced, with permission, from Varanat et al
(2012)47
a b b
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Drug Dose Duration  Reference(s) EBM grade
Doxycycline 10 mg/kg PO
q12–24 h 
2–4 weeks Lappin and
Black (1999)35
IV











Marbofloxacin 5 mg/kg PO
q24h 








2 months Varanat et al
(2009)7
IV
Suggested treatment for bartonellosis in cats Table 3
Post mortem evidence of pyogranulomatous
myocarditis and diaphragmatic myositis 
associated with B henselae infection was also
obtained in two cats (Figure 1).47
Lameness and pain during limb palpation
were observed in a cat affected by recurrent
osteomyelitis and polyarthritis associated
with B vinsonii subspecies berkhoffii infection
and bacteraemia.7
In conclusion, most cats naturally infected
by B henselae do not show clinical signs. The
identification of Bartonella infection in cats
with disease should prompt a critical assess-
ment of the role of the infection in the causa-
tion of the clinical signs and the exclusion of
other compatible diagnoses.
Diagnosis
Bartonella laboratory testing is required for
feline blood donors, for pet cats belonging to
immunosuppressed persons, or when a
human Bartonella-related disease is diagnosed
in a cat’s home.
Isolation of the bacterium is the gold stan-
dard, but because of the high prevalence of
infection in healthy cats in endemic areas, a
positive culture is not confirmatory,  and other
compatible diagnoses must be ruled out.
The disease is, therefore, diagnosed on the
basis of exclusion, and by assessing the
response to therapy. The ex juvantibus infer-
ence about disease causation from the
observed response to a treatment may 
apply to uveitis, endocarditis, myocarditis,
osteoarthritis and multifocal central nervous
system (CNS) disease, which are considered
compatible with feline bartonellosis.
PCR may be used on samples of blood,
REV IEW / ABCD guidelines on Bartonella species infection
B henselae is the causative agent of cat scratch disease (Figure
2). This is a usually self-limiting regional lymphadenopathy that
develops after a primary papular lesion and lasts for a few weeks
to several months.48 Abscessation of the lymph node and 
systemic signs are occasionally reported. Atypical forms and an
expanding spectrum of clinical conditions are being associated
with B henselae infection, such as neuroretinitis, uveitis, endo-
carditis and neurological disorders.48–52 An unusual
case of cat scratch disease has been reported
in a veterinarian affected by persistent fever
and back pain after an accidental needle
puncture.53 The occupational risk of expo-
sure to arthropod vectors, as well as the
reservoir host, should be also considered
by veterinarians for this vector-borne dis-
ease.54 Immunocompetent individuals may
even experience subclinical Bartonella infec-
tion; conversely, immunocompromised persons
suffer from clinical forms of a disseminated infection that may be
fatal if untreated.55,56
D i s ea se  i n  h umans
Zoonosis
B henselae is the
causative agent of cat
scratch disease.
aqueous humour, cerebrospinal fluid or tis-
sues, and several gene targets have been stud-
ied. To reduce false-negative test results,
repeated blood cultures are required or PCR
performed on more than one kind of biologi-
cal sample (blood, lymph node, oral swab). 
Serology (IFAT or ELISA) is more useful for
exclusion than for confirmation of the infec-
tion because of the low positive predictive
value (39–46%) compared with the good 
negative predictive value (87–97%) [EBM
grade III].13,15,17,20 Bartonella IgM antibodies are
found in experimentally and naturally infect-
ed cats but their occurrence seems not to be
related to bacteraemia [EBM grade II].57
Treatment
Treatment is recommended in the rare cases
where Bartonella has actually caused disease
(eg, endocarditis).
Figure 2 Immunohistochemical identification of B henselae in a case of 
cat scratch disease. With Warthin-Starry silver stain, these coccobacillary
pathogens can be seen singly, in small clumps or in chains in necrotic foci.
Courtesy of Dharam Ramnani, Webpathology.com
EBM grades
The ranking system
for grading the level
of evidence of
various statements
within this article is
described on 
page 533 of this
Special Issue.
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Cats are the main reservoir for B henselae, the agent of cat
scratch disease and more severe human diseases observed in
severely immunosuppressed persons such as bacillary
angiomatosis and peliosis hepatis. Recognised risk factors for
bacteraemia in cats are young age, infestation with fleas, out-
door lifestyle and a multicat environment.13,15,20,48
There is no evidence of benefit to cats or their owners from
routine testing of the pet for Bartonella infection or from anti -
biotic treatment of healthy antibody positive cats [EBM grade
IV].61 Infection does not always lead to clinical signs in healthy
persons and many of them have antibodies.55
Owner education by practitioners about Bartonella transmis-
sion is essential to reduce the zoonotic risk, and the presence of
immunosuppressed persons in the cat family should be specifi-
cally considered. It is recommended that immunosuppressed
persons are allowed to keep their pet cat or to adopt a new one
and a few simple tips summarised on the right can minimise their
exposure risk.61,62
Pub l i c  h e a l t h  c on s i d e r a t i o n s
Recommendations for prevention of B henselae
infection in immunocompromised persons61,62
< Immunocompromised owners should adopt
cats that are older than 1 year, flea-free, in
good health, not from shelters or multicat
households, and have no history of contact
with cats of unknown health status
< Strict flea control should be exercised under
veterinary supervision
< Rough play should be avoided, and the cat’s
claws kept trimmed
< Any wound should promptly be cleaned with
soap and water, and medical advice sought
< Cats should be kept indoors to avoid exposure
to fleas and other possible vectors, and also 
to prevent other zoonotic risks
Current therapeutic strategies in cats (Table
3) are based on in vitro studies and human
bartonellosis. Data from controlled efficacy
studies in cats are lacking. A cat affected by
recurrent osteomyelitis and polyarthritis asso-
ciated with B vinsonii subspecies berkhoffii
genotype II infection and bacteraemia recov-
ered after therapy with azithromycin (10
mg/kg PO q48h for 3 months) and amoxi-
cillin–clavulanate (62.5 mg PO q12 for 2
months) [EBM grade IV].7
After natural or experimental infection with
B henselae or B clarridgeiae, healthy cats have
been treated to eliminate bacteraemia and
many drugs have been evaluated: doxycy-
cline, amoxicillin, amoxicillin-clavulanate,
enrofloxacin, erythromycin and rifam picin
[EBM grade II].58–60 Based on these results,
clearance of bacteraemia cannot be guaran-
teed and, in the case of failure, there is the 
risk of inducing antimicrobial resistance.
Treatment of healthy carriers, therefore, can-
not be considered an effective measure for
eliminating the zoonotic risk, as is sometimes
requested in human cases of cat scratch dis-
ease or where other Bartonella-related disease
occurs in a family member.
Prevention
Based on transmission studies to date, strict
flea (and tick) control is the only successful
preventive measure. There is no vaccine avail-
able against Bartonella infection.
< B henselae is the most common Bartonella species infecting cats, which are the main reservoir for this bacterium.
< B henselae is the causative agent of cat scratch disease in man, a self-limiting regional lymphadenopathy.
< B henselae is naturally transmitted among cats by the faeces of Ctenocephalides felis felis fleas; contact
infections do not occur. Blood transfusion also represents a risk.
< Most cats naturally infected by B henselae do not show clinical signs but sporadic cases of endocardial,
myocardial or ocular feline disease have been reported.
< Other Bartonella species, for which cats are accidental hosts, may have more pathogenic potential.
< Antibodies are not protective, and seropositive cats may be reinfected.
< Bartonellosis is diagnosed on the basis of exclusion, and by assessing the response to antibiotic therapy.
< Testing healthy cats or people is of no benefit.
< Treatment of healthy carriers is no measure for eliminating the zoonotic risk.
< Strict flea and tick control is the only effective preventive measure.
KEY POINTS
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